Raabe College of Pharmacy, Ohio Northern University, Ada, OH 45810, USA.
Psychopharmacology (Berl). 2009 Nov;206(4):653-64. doi: 10.1007/s00213-008-1339-9. Epub 2008 Oct 9.
Deficits in memory and attention are broadly acknowledged during psychosis; however, experiments on modeled psychosis often test working memory without systematic manipulation of attentional demands.
The major research goal was discovering which neurobehavioral processes, attention, or memory contributed more to drug-provoked performance deficits.
Rats were trained to perform operant ratio discrimination (RD) tasks wherein the number of presses at a rear-wall lever was discriminated using one of two front-wall levers. Effects from four psychotomimetic drugs, the serotonin agonist 2,5-dimethoxy-4-iodoamphetamine, the noncompetitive NMDA-glutamate receptor antagonist phencyclidine (PCP), and two CB1-selective cannabinoid agonists, WIN 55,512-2 and AM 411, were assessed using a signal detection analytical overlay to dissociate cognitive from noncognitive motor and motivational disruptions. Further methods allowed dissociation of attention compromises from mnemonic deficits.
For each test compound, at least one dose elicited decreased RD accuracy without affecting response rates, and task difficulty was shown to be a crucial dictator of accuracy effect specificities. Effects from both PCP and WIN 55,512-2 biased animals to select the response lever conditioned for denser reinforcement. The same two drugs rendered peculiar response patterns in distracter light session components, considering light blinks were included to divert subjects' attention away from task-relevant information. The response patterns determined during distracter components of PCP/WIN testing sessions, counterintuitively, suggest performance enhancement.
Comprehensive viewing of RD performance patterns after drug administration indicates that sustained attention and transient information management are significantly impaired during the drug-induced psychosis state, while selective attention is less affected.
在精神病中,记忆和注意力缺陷是广泛公认的;然而,模拟精神病的实验通常在没有系统地操纵注意力需求的情况下测试工作记忆。
主要的研究目标是发现哪些神经行为过程,注意力或记忆对药物引起的表现缺陷贡献更大。
大鼠接受操作比率辨别(RD)任务的训练,其中使用两个前壁杠杆之一来辨别后壁杠杆的按压次数。使用信号检测分析覆盖来分离认知与非认知运动和动机干扰,评估了四种精神拟态药物的作用,即 5-二甲基氧基-4-碘苯丙胺(DOI)、非竞争性 NMDA 谷氨酸受体拮抗剂苯环利定(PCP)以及两种 CB1 选择性大麻素激动剂 WIN 55,512-2 和 AM 411。进一步的方法允许从记忆缺陷中分离注意力缺陷。
对于每种测试化合物,至少有一种剂量会降低 RD 准确性而不影响反应率,并且任务难度被证明是特异性准确性影响的关键决定因素。PCP 和 WIN 55,512-2 都使动物偏向于选择条件反射密度较高的反应杠杆。这两种药物在分心物光会话组件中产生了奇特的反应模式,因为光闪烁被包括在内,以将注意力从与任务相关的信息上转移开。考虑到光闪烁被包括在内,以将注意力从与任务相关的信息上转移开,在分心物光会话组件中确定的反应模式令人惊讶地表明性能增强。
药物给药后 RD 性能模式的综合观察表明,在药物诱导的精神病状态下,持续注意力和瞬态信息管理明显受损,而选择性注意力受影响较小。